Myelin basic protein (MBP)-specific T-cells may play an important role in the pathogenesis of multiple sclerosis (MS). Vaccination with irradiated autologous MBP-reactive T-cells (T-cell vaccination) induces cytolytic anti-clonotypic T-cells that specifically recognize and lyse the immunizing T-cells, resulting in selective depletion of circulating MBP-reactive T-cells in patients with MS. The current application is designed to elucidate molecular mechanisms underlying T-cell vaccination and clonotypic regulation of MBP-reactive T-cells in MS. There are three specific aims: (1) to generate and characterize anti-clonotypic T-cells that are induced by T-cell vaccination and specifically regulate MBP reactive T-cells in MS. Selection of DR2 restricted 84-102 specific T-cells for vaccination is based on potential structural similarities in their T-cell receptors (TCR) and their representative value for a large proportion of the MS population, (2) to locate and identify the target TCR regions and common sequence motifs recognized by anti-clonotypic T-cells and (3) to design MHC class I bound TCR peptides and evaluate their specificities and efficiency in eliciting cytolytic anti-clonotypic T-cells in DR2 MS patients. The purpose of this study is to improve and simplify the current T-cell vaccination protocol using a peptide-based vaccination approach. A large panel of cytolytic anti-clonotypic T-cell lines will be generated from MS patients vaccinated with autologous DR2-restricted T-cell clones specific for the immunodominant MBP peptide (84-102). The resulting anti-clonotypic T-cell lines will be characterized for their recognition pattern(s) towards the immunizing T-cell clones. V or V gene segments of the immunizing T-cell clones will be introduced genetically into autologous B-cells with truncation/deletion to identify and narrow down the TCR region/sequences capable of eliciting the anti-clonotypic T-cell responses. Specific attention will be given to identifying common sequence motifs within the target region(s) in the context of appropriate MHC class I molecule(s). Based on the obtained sequences data, a panel of short peptides will be designed and evaluated for their specificity and efficiency in eliciting cytolytic anti-clonotypic T-cell responses in DR2 MS patients. A MHC class I bound peptide(s) designed to incorporate common sequence motifs characteristic of DR2-restricted 84-102 specific T-cells will have great potential in the treatment of a large proportion of patients with MS.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
1R01NS036140-01A1
Application #
2471928
Study Section
Immunological Sciences Study Section (IMS)
Program Officer
Kerza-Kwiatecki, a P
Project Start
1997-09-30
Project End
2001-07-31
Budget Start
1997-09-30
Budget End
1998-07-31
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Neurology
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Zhang, Jingwu Z; Rivera, Victor M; Tejada-Simon, Maria V et al. (2002) T cell vaccination in multiple sclerosis: results of a preliminary study. J Neurol 249:212-8
Zhang, Jingwu (2002) T-cell vaccination for autoimmune diseases: immunologic lessons and clinical experience in multiple sclerosis. Expert Rev Vaccines 1:285-92
Zhang, J (2001) T-cell vaccination in multiple sclerosis: immunoregulatory mechanism and prospects for therapy. Crit Rev Immunol 21:41-55
Tejada-Simon, M V; Hong, J; Rivera, V M et al. (2001) Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals. Eur J Immunol 31:907-17
Tejada-Simon, M V; Zang, Y C; Yang, D et al. (2000) Aberrant T cell responses to myelin antigens during clinical exacerbation in patients with multiple sclerosis. Int Immunol 12:1641-50
Zang, Y C; Hong, J; Rivera, V M et al. (2000) Preferential recognition of TCR hypervariable regions by human anti-idiotypic T cells induced by T cell vaccination. J Immunol 164:4011-7
Hong, J; Zang, Y C; Tejada-Simon, M V et al. (2000) Reactivity and regulatory properties of human anti-idiotypic antibodies induced by T cell vaccination. J Immunol 165:6858-64
Zang, Y C; Kozovska, M M; Hong, J et al. (1999) Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis. Eur J Immunol 29:1692-700
Singh, R A; Zang, Y C; Shrivastava, A et al. (1999) Th1 and Th2 deviation of myelin-autoreactive T cells by altered peptide ligands is associated with reciprocal regulation of Lck, Fyn, and ZAP-70. J Immunol 163:6393-402
Zang, Y C; Kozovska, M; Aebischer, I et al. (1998) Restricted TCR Valpha gene rearrangements in T cells recognizing an immunodominant peptide of myelin basic protein in DR2 patients with multiple sclerosis. Int Immunol 10:991-8